Genetic overlap between Alzheimer’s disease (AD) and two significant cardiovascular disease risk factors — high levels of inflammatory C-reactive protein (CRP) and plasma lipids or fats — has been identified by researchers. The findings suggest the two cardiovascular phenotypes play a role in AD risk and perhaps offer a new avenue for potentially delaying disease progression.